View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Parkinson's Disease/Movement Disorders News

SPONSORED CONTENT
Save
SPONSORED CONTENT
August 20, 2024
1 min read
Save

Aruna Bio secures US patent for exosome-derived neuroinflammation treatment

Aruna Bio secures US patent for exosome-derived neuroinflammation treatment

A Georgia-based biotechnology company has secured a U.S. patent for an exosome-based therapy to treat neuroinflammation that occurs in a range of neurodegenerative disease, according to the manufacturer.

SPONSORED CONTENT
August 19, 2024
2 min read
Save

Study: Dementia diagnosed later in Parkinson’s disease course

Study: Dementia diagnosed later in Parkinson’s disease course

In two large trials of individuals with Parkinson’s disease, dementia occurred less frequently and later in the disease course than previously thought, according to new research published in Neurology.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
August 19, 2024
1 min read
Save

Patient enrollment begins in study of novel light therapy for Parkinson’s disease

Patient enrollment begins in study of novel light therapy for Parkinson’s disease

The first 100 patients have been enrolled in a clinical trial investigating a novel light therapy device intended to treat individuals with Parkinson’s disease, according to the manufacturer.

SPONSORED CONTENT
August 13, 2024
1 min read
Save

FDA approves Asleep Deep Brain Stimulation surgery for Parkinson’s, essential tremor

FDA approves Asleep Deep Brain Stimulation surgery for Parkinson’s, essential tremor

The FDA has approved Medtronic’s Asleep Deep Brain Stimulation surgery for individuals diagnosed with Parkinson’s disease as well as those with essential tremor, according to the manufacturer.

SPONSORED CONTENT
August 08, 2024
1 min read
Save

FDA approves Crexont extended-release capsules for Parkinson’s disease

FDA approves Crexont extended-release capsules for Parkinson’s disease

The FDA has approved Crexont extended-release capsules for the treatment of Parkinson’s disease, according to the manufacturer.

SPONSORED CONTENT
July 26, 2024
2 min read
Save

Study: Body composition associated with neurodegenerative disease, brain aging

Study: Body composition associated with neurodegenerative disease, brain aging

Body composition patterns associated with weight and fat distribution were strongly correlated with neurodegenerative disease and brain aging, mediated by cardiovascular disease, according to research published in Neurology.

SPONSORED CONTENT
July 25, 2024
1 min read
Save

Annovis secures US patent for buntanetap

Annovis secures US patent for buntanetap

Annovis Bio Inc. has secured a U.S. patent for methods of treating acute traumatic brain injuries with its lead drug candidate, an oral, small molecule neurotoxic protein inhibitor.

SPONSORED CONTENT
July 24, 2024
2 min read
Save

‘On’ time improvement significant at day 3 with combination therapy for Parkinson’s

‘On’ time improvement significant at day 3 with combination therapy for Parkinson’s

Improvements in “on” time were observed as early as day 3 after treatment initiation with an investigational subcutaneous combination therapy for Parkinson’s disease, which also led to significant improvement by day 7, data show.

SPONSORED CONTENT
July 18, 2024
1 min read
Save

Antidopaminergics linked to worse cognitive, functional outcomes in HD at 6 years

Antidopaminergics linked to worse cognitive, functional outcomes in HD at 6 years

Antidopaminergic medications were linked to worsening cognitive and functional effects that accelerate disease progression in Huntington’s disease, according to research presented at the Congress of the European Academy of Neurology.

SPONSORED CONTENT
July 17, 2024
1 min read
Save

FDA grants RMAT designation for stiff person syndrome therapy

FDA grants RMAT designation for stiff person syndrome therapy

The FDA has granted Regenerative Medicine Advanced Therapy designation to a Bay Area-based biopharmaceutical company for its autologous, fully human CD19 chimeric antigen receptor to treat those with refractory stiff person syndrome.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails